Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Consensus Points Towards Bright Future for Lantronix

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Neurotechnology
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Over the past quarter, analysts have shared a range of opinions on Lantronix (NASDAQ: LTRX), with a mix of optimism and caution. Let’s delve into the recent assessments and key insights:

Total Ratings: Four analysts have weighed in, all leaning towards a bullish outlook.

Recent Changes: In the last month, there was one additional bullish rating added to the mix.

Price Targets: The average 12-month price target for Lantronix stands at $7.88, with a high estimate of $9.00 and a low estimate of $7.00. This average reflects a decrease of 18.51% from the previous target of $9.67.

Analyst Actions: Noteworthy moves include Ryan Koontz of Needham revising the buy rating down to $7.00 from $8.50, and Scott Searle of Roth MKM also adjusting the buy rating to $9.00 from $12.00.

Analyst consensus points towards a bright future for Lantronix, with a Strong Buy rating based on five buy recommendations.

Analysis of LTRX Stock Price Decline on March 12, 2024: Factors to Consider for Investors

On March 12, 2024, LTRX stock experienced a slight decrease in its price momentum. LTRX opened at $3.79, which was $0.04 higher than its previous close. Throughout the trading day, the price of LTRX shares dropped by $0.05, representing a 1.33% decrease from the previous close.

This decline in stock price could be attributed to various factors such as market conditions, company performance, or investor sentiment. Investors may have reacted to news or events that impacted the company’s outlook, leading to a decrease in demand for LTRX shares.

For investors considering LTRX stock, it is essential to conduct thorough research and analysis to understand the reasons behind the price decline and evaluate the company’s long-term prospects. Consulting with a financial advisor or conducting further research on the company’s financial health and growth prospects can help investors make informed decisions about their investment portfolio.

Lantronix Inc. (LTRX) Financial Results: Revenue Flat, Net Income Decreases – March 12, 2024

On March 12, 2024, investors closely monitored the stock performance of Lantronix Inc. (LTRX) as the company reported its financial results for the past year and the most recent quarter. Lantronix reported total revenue of $131.19 million for the past year, which remained flat compared to the previous year. Total revenue saw a 12.13% increase from the previous quarter, reaching $37.04 million. Despite the increase in revenue from the previous quarter, Lantronix reported a net income of -$8.98 million for the past year, marking a significant decrease of 67.47% compared to the previous year. The net income also decreased by 37.49% from the previous quarter, standing at -$2.59 million. The earnings per share (EPS) for Lantronix decreased by 50.94% from the previous year, reaching -$0.25, and decreased by 36.08% from the previous quarter, standing at -$0.07. The stock performance of Lantronix on March 12, 2024, reflected these financial results, with investors reacting to the decrease in net income and EPS. By staying informed about the latest financial updates and trends, investors can better navigate the stock market and make strategic investment decisions.

Tags: LTRX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Carlisle Companies A Decade of Impressive Growth and Returns

Biotechnology Trading online

Heartbeam Inc BEAT Stock Rises on New Patents and Analyst Optimism

Bright Green Announces Major Expansion Plans with Dalsem Greenhouse Technologies BV

Recommended

Biotechnology Market Capitalization

BioAffinity Technologies Resumes Trading on Stock Market What Investors Need to Know

2 years ago
Broadridge Stock

Broadridge Financial: Strategic Positioning Drives Market Leadership

7 days ago
TMUS stock news

MeridianLink NYSE MLNK Reports Q4 2023 Earnings Below Analyst Predictions Optimistic for 2024

2 years ago
Absence_on_WalmartOne

Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism

Marsh McLennan Appoints New Leader to Drive International Expansion Strategy

Polestar Faces Mounting Challenges as Recall Compounds Financial Woes

Kratos Defense Secures Coveted Spot in S&P MidCap 400 Index

American Express Doubles Down on Premium Market Strategy

Snowflake Gains Momentum with Leadership Shift and Strategic Alliances

Trending

Dentsply Sirona Stock
Earnings

Dentsply Sirona’s Rocky Road to Recovery

by Dieter Jaworski
September 22, 2025
0

Dentsply Sirona, a leading manufacturer of dental products and technologies, finds itself navigating a period of significant...

VanEck Video Gaming and eSports ETF Stock

A Closer Look at the VanEck Gaming ETF: A Resilient Tech Niche

September 22, 2025
Roku Stock

Roku Stock: Strong Fundamentals Clash with Institutional Selling

September 22, 2025
Anavex Stock

Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism

September 22, 2025
Marsh McLennan Stock

Marsh McLennan Appoints New Leader to Drive International Expansion Strategy

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dentsply Sirona’s Rocky Road to Recovery
  • A Closer Look at the VanEck Gaming ETF: A Resilient Tech Niche
  • Roku Stock: Strong Fundamentals Clash with Institutional Selling

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com